68727-0745 Vyxeos - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

68727-0745

Brand Name:

Vyxeos

Generic Name:

(daunorubicin and cytarabine) liposome

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION

Administration Route:

Intravenous

Substances:

Name: CYTARABINE

Strength: 100.0

Unit: mg/20mL

Name: DAUNORUBICIN

Strength: 44.0

Unit: mg/20mL

Packages:

Code: 68727-0745-01

Description: 20 mL in 1 VIAL (68727-745-01)

Effective Date: Aug. 3, 2017

Discontinued:

Code: 68727-0745-02

Description: 40 mL in 1 CARTON (68727-745-02)

Effective Date: Aug. 3, 2017

Discontinued:

Code: 68727-0745-05

Description: 100 mL in 1 CARTON (68727-745-05)

Effective Date: Aug. 3, 2017

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Antitumor Antibiotic & Antimetabolite

Minor Class:

Anthracycline & Pyrimidine Analog

Orphan Drug Designation:

Status:

In Use